Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Open Cosmos | Sep 2026Participated | $348 MOther Equity | |
Viscaria | Jun 2026Participated | $178 MOther Equity | |
May Health | Mar 2026Participated | $12 MOther Equity | |
Rail-Flow | Dec 2025Led | $15 MSeries A | |
May Health | May 2024Led | $25 MSeries B | |
Minervax | Oct 2023Participated | $57 MOther Equity | |
Open Cosmos | Sep 2023Participated | $50 MSeries B | |
Tado | Jan 2023Led | $47 MOther Equity | |
Minervax | Dec 2022Led | $77 MDebt | |
Cinclus Pharma | May 2022Led | $24 MOther Equity | |
Open Cosmos | Sep 2026Participated | $348 MOther Equity | |
Viscaria | Jun 2026Participated | $178 MOther Equity | |
May Health | Mar 2026Participated | $12 MOther Equity | |
Rail-Flow | Dec 2025Led | $15 MSeries A | |
May Health | May 2024Led | $25 MSeries B | |
Minervax | Oct 2023Participated | $57 MOther Equity | |
Open Cosmos | Sep 2023Participated | $50 MSeries B | |
Tado | Jan 2023Led | $47 MOther Equity | |
Minervax | Dec 2022Led | $77 MDebt | |
Cinclus Pharma | May 2022Led | $24 MOther Equity |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 0 |
| Series B | 1 | 1 |
| Other Equity | 2 | 4 |
| Debt | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 1 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 1 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 5 |
| Networks, Cloud & Communication | 2 |
| Hardware & Robotics | 2 |
| Clean Energy & Sustainability | 2 |
| Space & Frontier Tech | 2 |
| Enterprise Software | 1 |
| Real Estate & Construction | 1 |
| Transportation & Logistics | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 3 |
| $25M-$50M | 2 |
| $50M-$100M | 3 |
| $100M-$250M | 1 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 9 |
| Indonesia | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Adjuvant Capital | 2 |
| Bpifrance | 2 |
| Claret Capital Partners | 2 |
| ETF Partners | 2 |
| Industrifonden | 2 |
| Pureos Bioventures | 2 |
| Sanofi Ventures | 2 |
| Sofinnova Partners | 2 |
| Sunstone Life Science Ventures | 2 |
| Wellington Partners | 2 |
| A&G | 1 |
| A&G Global Investors | 1 |
| Accenture Ventures | 1 |
| Avestria Ventures | 1 |
| Banco Santander | 1 |
| Bayern Kapital | 1 |
| Bonsai Partners | 1 |
| Climentum Capital | 1 |
| Convex Group | 1 |
| EIT InnoEnergy | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 5 | 50% |
| Participating | 5 | 50% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 40% |
| Co-led | 3 | 60% |
Team
Partner, CFO and Head of Financing
Founder and Managing Partner
Head of Microfinance